MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
6.65
+0.02
+0.30%
After Hours: 6.85 +0.2 +2.98% 19:57 12/16 EST
OPEN
6.65
PREV CLOSE
6.63
HIGH
6.90
LOW
6.50
VOLUME
1.32M
TURNOVER
--
52 WEEK HIGH
6.90
52 WEEK LOW
3.809
MARKET CAP
392.99M
P/E (TTM)
-4.6455
1D
5D
1M
3M
1Y
5Y
1D
Vanda Pharmaceuticals: Promising Pipeline and Regulatory Progress Drive Buy Rating
TipRanks · 13h ago
BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia
Reuters · 1d ago
Vanda Pharmaceuticals Rises on FDA Biologics License Application
Dow Jones · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow
Reuters · 1d ago
BUZZ-Vanda Pharmaceuticals rises after BLA for rare skin disease treatment
Reuters · 1d ago
VANDA PHARMACEUTICALS SHARES RISE 6.1% PREMARKET AFTER CO SUBMITS BIOLOGICS LICENSE APPLICATION FOR GPP DRUG
Reuters · 1d ago
Vanda Pharmaceuticals Submitted An FDA Biologics License Application For Imsidolimab For Generalized Pustular Psoriasis
Benzinga · 1d ago
Vanda Pharmaceuticals announces submission of BLA to FDA for imsidolimab
TipRanks · 1d ago
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.